Pietilä K, Mustonen J, Mörsky P, Seppälä E, Pasternack A, Koivula T
Clinic of Medicine, Tampere University Central Hospital, Finland.
Nephrol Dial Transplant. 1989;4(2):115-8.
We studied the effect of one haemodialysis treatment on the plasma concentrations of intact parathyroid hormone (PTH), total immunoreactive PTH (determined with an antibody against the mid-molecular part of the hormone), and ionised calcium in 25 patients on maintenance dialysis for chronic renal failure. During dialysis the calcium concentration in the external fluid was 1.75 mmol/l, which led to an increase in the plasma ionised calcium concentration from 1.23 +/- 0.07 mmol/l (mean +/- SD) at commencement of dialysis to a final 1.35 +/- 0.07 mmol/l (P less than 0.001). The plasma concentration of intact PTH decreased from 27.4 +/- 26.3 pmol/l to 13.0 +/- 19.1 pmol/l (P less than 0.001) during the treatment. Total immunoreactive PTH did not change, reflecting poor dialysability of PTH and PTH fragments. We also compared the dialysis-induced changes in the plasma concentrations of intact PTH and ionised calcium with those induced by a calcium infusion test. We conclude that in the majority of dialysis patients, one haemodialysis treatment with a relatively high external fluid calcium concentration can be used to assess the suppressibility of secondary hyperparathyroidism.
我们研究了一次血液透析治疗对25例慢性肾衰竭维持性透析患者血浆中完整甲状旁腺激素(PTH)、总免疫反应性PTH(用针对该激素中分子部分的抗体测定)和离子钙浓度的影响。透析过程中,外部液体中的钙浓度为1.75 mmol/L,这导致血浆离子钙浓度从透析开始时的1.23±0.07 mmol/L(均值±标准差)升至最终的1.35±0.07 mmol/L(P<0.001)。治疗期间,完整PTH的血浆浓度从27.4±26.3 pmol/L降至13.0±19.1 pmol/L(P<0.001)。总免疫反应性PTH未发生变化,这反映了PTH及PTH片段的透析性较差。我们还将透析引起的完整PTH和离子钙血浆浓度变化与钙输注试验引起的变化进行了比较。我们得出结论,对于大多数透析患者,采用相对较高外部液体钙浓度的一次血液透析治疗可用于评估继发性甲状旁腺功能亢进的可抑制性。